Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.1
13.44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Net Income (Common)
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Net Income (Common) Peer Comparison
1177
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
Net Income (Common)
HK$494.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
6%
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Net Income (Common)
HK$2.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
34%
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Net Income (Common)
¥2.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
27%
|
CAGR 10-Years
18%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
16%
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Net Income (Common)
HK$6.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Net Income (Common)
-$42m
|
CAGR 3-Years
38%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common)?
Net Income (Common)
494.1m
HKD
Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common) amounts to 494.1m HKD.
What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
Over the last year, the Net Income (Common) growth was -29%. The average annual Net Income (Common) growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been -5% over the past three years , -12% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
